Abbott DBS Post-Market Study of Outcomes for Indications Over Time
Status: Recruiting
Location: See all (47) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
The purpose of this international study is to evaluate long-term safety and effectiveness of Abbott deep brain stimulation (DBS) systems for all indications, including Parkinson's disease, essential tremor or other disabling tremor and dystonia.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Subject is scheduled for a new implant or IPG device replacement surgery with a market-released Abbott DBS system within 180 days.
• Subject, or a legally acceptable representative, must provide written informed consent prior to any study-related procedure.
Locations
United States
Arizona
University of Aizona Health Sciences
RECRUITING
Tucson
California
Cedars-Sinai Medical Center
RECRUITING
Los Angeles
University of California at Davis
RECRUITING
Sacramento
Colorado
Colorado Neurodiagnostics
TERMINATED
Littleton
Neurosurgery One
WITHDRAWN
Littleton
Florida
University of Miami Hospital
RECRUITING
Miami
University of South Florida - Department of Neurology
RECRUITING
Tampa
Illinois
Rush University Medical Center
RECRUITING
Chicago
Indiana
Indiana University
RECRUITING
Indianapolis
Kansas
Kansas University Medical Center
RECRUITING
Kansas City
Kentucky
University of Louisville
RECRUITING
Louisville
Louisiana
Willis-Knighton Medical Center
TERMINATED
Shreveport
Massachusetts
Beth Israe Deaconess Medical Center
RECRUITING
Boston
New Hampshire
Dartmouth Hitchcock Medical Center
RECRUITING
Lebanon
New York
Albany Medical Center
RECRUITING
Albany
Ohio
The Cleveland Clinic Foundation
RECRUITING
Cleveland
Ohio State Medical
RECRUITING
Columbus
Wright State University & Premier Health
WITHDRAWN
Fairborn
Pennsylvania
Center for Interventional Pain & Spine
WITHDRAWN
Exton
Thomas Jefferson Department or Neurosurgery
RECRUITING
Philadelphia
Allegheny General Hospital Department of Neurosurgery
TERMINATED
Pittsburgh
Texas
Texas Movement Disorder Specialist
RECRUITING
Georgetown
Utah
University of Utah Hospital
RECRUITING
Salt Lake City
Other Locations
Australia
Royal Melbourne Hospital - City Campus
RECRUITING
Parkville
Princess Alexandra Hospital
RECRUITING
Woolloongabba
Finland
Helsinki University Central Hospital
RECRUITING
Helsinki
France
CHU Gabriel Montpied
WITHDRAWN
Clermont-ferrand
CHU Hopital Pasteur
RECRUITING
Nice
Fondation Rothchild
WITHDRAWN
Paris
CHU de St Etienne
RECRUITING
Saint-etienne
Germany
Medizinische Einrichtungen der Universität Düsseldorf
RECRUITING
Düsseldorf
UKE Hamburg (Universitatsklinik Eppendorf)
RECRUITING
Hamburg
UNIVERSITATSMEDIZIN der Johannes Gutenberg-Universität Mainz
RECRUITING
Mainz
Universitätsklinikum Münster
RECRUITING
Münster
Universitäts Klinikum Tübingen
RECRUITING
Tübingen
Italy
Az.Osp. Universitaria di Ferrara
TERMINATED
Cona
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
RECRUITING
Milan
Policlinico Universitario A. Gemelli
RECRUITING
Rome
Spain
Hospital Universitari Germans Trias I Pujol
RECRUITING
Badalona
Hospital Universitario de la Princesa
RECRUITING
Madrid
Hospital Virgen de Rocio
RECRUITING
Seville
Taiwan
Hualien Tzu Chi Hospital
RECRUITING
Hualien City
Chang Gung Memorial Hospital
RECRUITING
Linkou District
United Kingdom
Southmead Hospita
WITHDRAWN
Bristol
Queen Elizabeth University Hospital
RECRUITING
Glasgow
The Walton Centre
RECRUITING
Liverpool
King's College Hospital
RECRUITING
London
Contact Information
Primary
Natalie Brill, PhD
Natalie.Brill@abbott.com
+15122864383
Backup
Shirisha Chiluka
Shirisha.Chiluka@abbott.com
972-526-4820
Time Frame
Start Date: 2019-11-26
Estimated Completion Date: 2030-09
Participants
Target number of participants: 1000
Treatments
Deep brain stimulation
Subjects implanted with an Abbott DBS system
Authors
Daniel Gaudin, David VanSickle, Luisa Solis-Cohen, Franck Durif, Cecile Hubsch, Alan Whone, MariaChiara Sensi
Related Therapeutic Areas
Sponsors
Leads: Abbott Medical Devices